October 31, 2024 Endocrinologic and Metabolic Drugs Advisory Committee



The Committee will discuss new drug application 210934, for sotagliflozin oral tablet, submitted by Lexicon Pharmaceuticals, Inc., …

Be the first to comment

Leave a Reply

Your email address will not be published.


*